Cyprus Shuts Down 1,300 Illegal Med Websites

Cyprus: For the 13th consecutive year, the Republic of Cyprus actively participated in Operation PANGEA XVI, held from October 3 to 10, 2023.

This global initiative, involving 89 INTERPOL Member Countries, aimed to detect and seize counterfeit medicines and medical devices circulating online.

Coordinated by INTERPOL, EUROPOL, the World Customs Organization (WCO), and other entities, the operation targeted illegal pharmaceutical products worldwide, resulting in seizures totaling over €6.5 million.

Notably, 19% of the confiscated items were psychotherapeutic preparations. Additionally, 1,300 illegal websites were identified and removed, leading to 325 ongoing investigations and 72 arrests.

In Cyprus, the PANGEA XVI operation saw collaboration among various agencies, including Pharmaceutical Services, Customs, Postal Services, Health Services, and the Police, responsible for overall coordination.

Simultaneously, joint coordinated operations, supported by search warrants, resulted in the seizure of over 5,000 products subject to various prohibitions and restrictions, aligning with Cyprus legislation.

INTERPOL Secretary General, Mr. Jürgen Stock, emphasized the global threat posed by counterfeit pharmaceuticals and the misuse of regulated medicines, underlining Operation PANGEA XVI’s success in removing harmful preparations from the market and dismantling criminal networks engaged in falsified medicines trafficking.

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’